Tuesday, March 25, 2008

The New Name of the Game: Adherence - PharmExec

Dr. Andree Bates' recent article in Pharmaceutical Executive summarizes pharma's challenge well. She states: "even the best-intentioned patient adherence program is doomed to fail unless pharmaceutical organizations:
1. Evaluate underlying causes for noncompliance with their brand
2. Address barriers to implementation
3. Understand the ROI"